Article Details

Time to Reconsider Acorda Therapeutics Inc (NASDAQ:ACOR) After More Short Sellers?

Retrieved on: 2018-04-16 21:07:30

Tags for this article:

Click the tags to see associated articles and topics

Time to Reconsider Acorda Therapeutics Inc (NASDAQ:ACOR) After More Short Sellers?. View article details on hiswai:

Excerpt

<div><b>Leucadia National Corporation</b> holds 13,392 shares or 0.02% of its portfolio. Dekabank Deutsche Girozentrale holds 0% or 23,400 shares. Proshare Advsr Lc reported 33,040 shares. State Street Corp reported 0% in Acorda Therapeutics, Inc. (NASDAQ:ACOR). State Of Wisconsin Investment Board ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up